GlassScriptPhysician profile
Thomas Westover
NPI 1972609899
$11,368.56
in general payments reported to CMS, 2019-2025
11 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what 93% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $2,067 · 2021: $108 · 2022: $2,970 · 2023: $3,135 · 2024: $168 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,446 · Travel and Lodging: $1,075 · Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,446.00 |
| Travel and Lodging | $1,074.58 |
| Food and Beverage | $722.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $3,278.68 | 2023-2025 | Voxzogo 1.2mg |
| Illumina, INC. | $2,989.68 | 2022-2025 | Genetic Disease Testing |
| Alexion Pharmaceuticals, INC. | $2,000.00 | 2020 | |
| Bio-Rad Laboratories, INC. | $1,620.00 | 2025 | Blood Typing |
| Lupin INC. | $952.38 | 2019 | |
| Ge Healthcare | $154.93 | 2020-2024 | |
| Acadia Pharmaceuticals INC | $118.21 | 2025 | Daybue |
| Agile Therapeutics, INC. | $107.73 | 2021 | |
| Pfizer INC. | $99.80 | 2025 | |
| Amag Pharmaceuticals, INC. | $28.31 | 2019 | |
| Vanda Pharmaceuticals INC. | $18.84 | 2025 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Westover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.